Pinealon
Glu-Asp-Arg · EDR
Pinealon is the Glu-Asp-Arg tripeptide investigated in experimental oxidative-stress models. Its EDR sequence is different from the AEDG sequence of Epitalon.
Reviewed September 2026
- Residues
- 3. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
- Average mass
- 418.40 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
- pI
- 4.37 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.
Primary structure
Sequence
Peptide. Sequence describes the reference peptide, not a tested supplier lot.
Calculated properties
| Formula | C15H26N6O8 |
|---|---|
| Monoisotopic mass | 418.1812 Da |
| Extinction coefficient at 280 nm | None (no Tyr or Trp) |
| A280 at 1 mg/mL | Not measurable |
| Residues | 3 |
| Average mass | 418.40 Da |
| pI | 4.37 (theoretical) |
| Aliases | Glu-Asp-Arg, EDR |
|---|---|
| Sequence | EDR |
| Research area | Neurological |
Property basis and sources
These describe the reference compound or formulation, not identification or testing of the supplied lot.
Calculation scope: the stored canonical amino-acid sequence with free N- and C-termini, no other modifications or counterions. This specifies a reference form, not the chemical form or identity of a sold lot.
- Residues: 3 (calculated). Count of residues in the stored canonical reference sequence; terminal groups are not extra residues. Residues source 1
- Average mass: 418.40 Da (calculated). Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded. Average mass source 1 Average mass source 2 Average mass source 3
- pI: 4.37 (theoretical) (calculated). Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation. pI source 1 pI source 2
Residue composition
- Unique residues
- 3
- Most common
- Glutamic acid
- Nonpolar residues
- 0
- Other classified residues
- 3
Glutamic acid is the most common residue (1). The calculated charge at pH 7 is net negative (-1.01).
Reference scope and linked records
Reference type: Peptide.
This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.
Catalogue context: Pinealon. The product retains its own name and specification; this link does not certify equivalence to published study material.
Related references
Sources and their scope
- Pinealon, cell viability and free-radical levels. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.
About Pinealon
Identity and context
The primary study explicitly identifies the synthetic tripeptide as Glu-Asp-Arg. Similar names and overlapping research themes should not obscure that chemical difference. This entry describes the peptide identity rather than a heterogeneous pineal extract.
Reference classification
Peptide. The linked catalogue product is Pinealon. This reference does not independently authenticate the material supplied.
Storage and handling
Analytical specification
Match the EDR sequence and terminal chemistry to the analytical report. If an experiment depends on a particular stress model, document that model rather than describing an unqualified antioxidant effect.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| What the source examines | The investigators tested several cell systems, including cerebellar granule cells, neutrophils and PC12 cells. They reported changes in reactive oxygen species accumulation, cell viability and signalling-related measurements under induced oxidative stress. | Source context |
| What cannot be inferred | These are cell-model findings. They do not establish improved memory, neurological recovery or longevity in humans, and they do not show that a preparation is safe merely because the peptide is short. | Evidence limits |
References
Sources used for the data on this page, checked September 2026.
- Pinealon, cell viability and free-radical levelsPrimary source for the reference discussion; not lot-specific product evidence.
Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.